Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSerco Regulatory News (SRP)

Share Price Information for Serco (SRP)

Share Price is delayed by 15 minutes
Get Live Data
253.60    -0.20 (-0.08%)
Bid:
254.00
Ask:
254.80
Spread: 0.80 (0.315%)
Market Cap: £2.51b
SRP Live PriceLast checked at - London Stock Exchange

Intraday Serco Share Chart

Share Repurchase Programme

5 Mar 2024 07:00

RNS Number : 5397F
Serco Group PLC
05 March 2024
Β 

5 March 2024

LEI: 549300PT2CIHYN5GWJ21

Serco Group plc

(Serco or the Company)

Share Repurchase Programme

Serco today announces that, as outlined in the announcement of its 2023 Full Year Results on 29 February 2024, it intends to repurchase shares with a value of up to Β£140 million (the Programme).

Serco has instructed Barclays Capital Securities Limited (Barclays) and J.P. Morgan Securities plc (JPMS), together the Brokers, to execute the Programme.

Serco has entered into a non-discretionary and irrevocable instruction with Barclays in relation to the purchase by Barclays, acting as riskless principal during the period commencing today and ending no later than 5 August 2024, of the Company's Ordinary Shares of 2 pence each (Ordinary Shares) for an aggregate purchase price of up to Β£70 million. Following completion, or any termination of such instruction, the Programme will continue under a second non-discretionary and irrevocable instruction with JPMS in relation to the purchase by JPMS, acting as riskless principal during the period commencing following the end of the Barclays instruction and ending no later than 31 December 2024, subject to suspension for certain exceptional and/or unforeseen circumstances, of further Ordinary Shares for an aggregate purchase price of up to Β£70 million.

The aggregate number of shares acquired by the Company shall not exceed 115,617,039 Ordinary Shares as authorised by shareholders at the 2023 Annual General Meeting. It is intended that any Ordinary Shares purchased under the Programme will be transferred into treasury and subsequently cancelled. This arrangement is in accordance with Chapter 12 of the Financial Conduct Authority's Listing Rules and the Company's general authority to repurchase shares.

The aggregate purchase price of the Ordinary Shares bought by the Brokers under the two instructions shall be no greater than Β£140 million. Each of the Brokers shall make a simultaneous on-sale of Ordinary Shares purchased under the instructions to Serco. The Brokers will make their trading decisions in relation to the Programme independently of, and uninfluenced by, Serco.

The Brokers may undertake transactions in Ordinary Shares (which may include sales and hedging activities, in addition to purchases which may take place on any available trading venue or on an over the counter basis) during the period of the Programme in order to manage their market exposure under the Programme. Disclosure of such transactions will not be made by the relevant Broker as a result of or as part of the Programme, but the Brokers will continue to make any disclosures they are otherwise legally required to make.

Ends

Β 

For further information please contact:

Paul Checketts, Head of Investor Relations, tel: +44 (0) 7718 195 074 or email: paul.checketts@serco.com

Marcus De Ville, Head of Media Relations, tel: +44 (0) 7738 898 550 or email: marcus.deville@serco.com

Β 

About Serco

Serco brings together the right people, the right technology and the right partners to create innovative solutions that make positive impact and address some of the most urgent and complex challenges facing the modern world. With a primary focus on serving governments globally, Serco's services are powered by more than 50,000 people working across defence, space, migration, justice, healthcare, mobility and customer services. Serco's core capabilities include service design and advisory, resourcing, complex programme management, systems integration, case management, engineering, and asset & facilities management. Underpinned by Serco's unique operating model, Serco drives innovation and supports customers from service discovery through to delivery. More information can be found at www.serco.com

Β 

Β 

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
MSCUSAWRSKUORAR
Date   Source Headline
5th Jun 20265:36 pmRNSTransaction in Own Shares
29th May 20265:35 pmRNSTransaction in Own Shares and Total Voting Rights
26th May 20267:00 amRNSSerco secures £270m contract from NNUH
22nd May 20265:14 pmRNSTransaction in Own Shares
15th May 20265:24 pmRNSTransaction in Own Shares
8th May 20265:25 pmRNSTransaction in Own Shares
30th Apr 20265:37 pmRNSTransactions in own shares and Total Voting Rights
24th Apr 20265:17 pmRNSTransactions in Own Shares
22nd Apr 20264:00 pmRNSResult of AGM
17th Apr 20265:34 pmRNSTransactions in Own Shares
10th Apr 20265:39 pmRNSTransactions in Own Shares
10th Apr 20263:46 pmRNSDirector/PDMR Shareholding
7th Apr 20265:35 pmRNSDirector/PDMR Shareholding
31st Mar 20265:21 pmRNSTransactions in Own Shares and Total Voting Rights
27th Mar 20263:03 pmRNSDirector/PDMR Shareholding
20th Mar 20265:50 pmRNSTransaction in Own Shares
18th Mar 20265:15 pmRNSHolding(s) in Company
18th Mar 202611:00 amRNSPublication of the 2025 ARA and 2026 Notice of AGM
13th Mar 20265:25 pmRNSTransaction in Own Shares
11th Mar 20265:46 pmRNSTransaction in Own Shares and Total Voting Rights
5th Mar 20267:02 amRNSShare Repurchase Programme
5th Mar 20267:00 amRNS2025 full year results
19th Feb 20265:45 pmRNSHolding(s) in Company
9th Feb 20265:30 pmRNSHolding(s) in Company
5th Feb 202612:30 pmRNSHolding(s) in Company
2nd Feb 20265:45 pmRNSTotal Voting Rights and Capital
29th Jan 20265:30 pmRNSHolding(s) in Company
5th Jan 20265:30 pmRNSHolding(s) in Company
31st Dec 20259:00 amRNSTotal Voting Rights and Capital
31st Dec 20259:00 amRNSTotal Voting Rights and Capital
23rd Dec 20254:00 pmRNSHolding(s) in Company
23rd Dec 20254:00 pmRNSHolding(s) in Company
19th Dec 20257:30 amRNSCancellation of Treasury Shares
19th Dec 20257:30 amRNSCancellation of Treasury Shares
17th Dec 20257:01 amRNSCFO Retirement
17th Dec 20257:00 amRNSSerco pre-close trading update
4th Dec 20257:00 amRNSTransaction in Own Shares
3rd Dec 20254:30 pmRNSBlock listing Interim Review
3rd Dec 20257:00 amRNSTransaction in Own Shares
2nd Dec 20257:00 amRNSTransaction in Own Shares
1st Dec 20257:00 amRNSSerco awarded UK prison contract
28th Nov 20256:20 pmRNSTransactions in own shares and Total Voting Rights
28th Nov 20257:00 amRNSTransaction in Own Shares
27th Nov 20257:00 amRNSTransaction in Own Shares
26th Nov 20257:00 amRNSTransaction in Own Shares
25th Nov 20257:00 amRNSTransaction in Own Shares
24th Nov 20257:00 amRNSTransaction in Own Shares
21st Nov 20257:00 amRNSTransaction in Own Shares
20th Nov 20257:00 amRNSTransaction in Own Shares
19th Nov 20257:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.